logo

Pharmaceutical Blister Packaging Market Size (2024 - 2029)

The pharmaceutical blister packaging market is experiencing growth driven by innovations in packaging solutions and a focus on sustainable materials. This market's expansion is influenced by the need for effective delivery systems that ensure the safety and integrity of medicinal products. Blister packaging, known for its robustness and ability to protect against external contaminants, has evolved to meet the pharmaceutical industry's demands. The COVID-19 pandemic further accelerated the market's growth, highlighting the importance of packaging in medication transport and storage, despite challenges in raw material movement due to lockdowns.

Home Market Analysis Packaging Research Packaging Materials Research Pharmaceutical Blister Packaging Market Market Size

Market Size of Pharmaceutical Blister Packaging Industry

Pharmaceutical Blister Packaging Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 22.08 Billion
Market Size (2029) USD 31.62 Billion
CAGR (2024 - 2029) 7.45 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Pharmaceutical Blister Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Pharmaceutical Blister Packaging Market Analysis

The Pharmaceutical Blister Packaging Market size is estimated at USD 22.08 billion in 2024, and is expected to reach USD 31.62 billion by 2029, growing at a CAGR of 7.45% during the forecast period (2024-2029).

  • Blister packaging is crucial in the pharmaceutical industry. These specialized packaging solutions guarantee that medicinal products reach patients without tampering or damage. Blister packaging safeguards therapeutic commodities, keeping them moisture-free and shielded from external contaminants.
  • Blister packaging, enhanced with sensors, plays a key role in monitoring dosing activities and ensuring clinical trials' accuracy. Consider WestRock’s CerePak blister packs: they come equipped with concealed microprocessors and printed conductive inks, meticulously logging the date, time, and location of each dose. This feature is especially vital for treatment regimens that involve fluctuating dosages or a combination of placebo and active medications.
  • Blister packaging typically consists of thermoformed plastic, with lids made from paper, plastic, foil, or a combination. Another common variant utilizes solely foil, crafted through a cold-stretching process. Opaque options are available to shield light-sensitive medications from harmful UV rays.
  • Blister packaging is a durable solution for packaging and transporting medical essentials. It shields contents from impacts, moisture, and heat, enhancing the medicines' shelf life and transportability. The advantages of blister packaging became evident during the pandemic, as its surfaces were pivotal in the international transport and storage of medications. Yet, the potential for virus transfer via these surfaces highlighted areas for improvement, particularly in the outer materials, which packaging manufacturers will likely prioritize in the future.
  • However, strict regulations and policies targeting plastic packaging are expected to present a potential challenge to the growth of the pharmaceutical blister packaging segment during the forecast period. For instance, the United States (with 16 states already on board and more anticipated) and Europe have enacted laws to curb plastic waste.

Pharmaceutical Blister Packaging Industry Segmentation

The pharmaceutical blister packaging market tracks the demand for pharmaceutical blister packaging made of materials, including plastic, paper, and aluminum, around the globe.

The pharmaceutical blister packaging market is segmented by material (plastic [polyvinyl chloride (PVC), polypropylene (PP)], paper, and aluminum), technology (cold forming and thermoforming), geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.

By Material
Plastic (Poly Vinyl Chloride (PVC), Polypropylene (PP))
Paper
Aluminum
By Technology
Cold Forming
Thermoformed
By Geography
North America
Europe
Asia
Australia and New Zealand
Middle East and Africa
Latin America
Need A Different Region Or Segment?
Customize Now

Pharmaceutical Blister Packaging Market Size Summary

The pharmaceutical blister packaging market is experiencing steady growth, driven by the increasing demand for efficient and secure packaging solutions in the pharmaceutical industry. Blister packaging is essential for ensuring the safe, moisture-free, and tamper-proof delivery of medicinal products. This packaging method has evolved significantly since its inception in the 19th century, adapting to the diverse needs of the industry. The market is characterized by a focus on innovation, particularly in the development of recyclable materials and sustainable packaging solutions. Companies are actively engaging in research and development, as well as collaborations with material providers, to reduce carbon footprints and enhance the recyclability of packaging materials. The COVID-19 pandemic further highlighted the importance of blister packaging in maintaining the integrity of medications during transportation, although it also underscored the need for improvements in the materials used to prevent virus transmission.

The market is moderately competitive, with a mix of major and local players offering a variety of packaging solutions and technologies. The increasing global consumption of medicines, coupled with government initiatives promoting bulk drug manufacturing and the use of recyclable materials, is driving the demand for blister packaging. The rise in Active Pharmaceutical Ingredients (APIs) production and the expansion of manufacturing facilities are also contributing to this demand. Companies like Amcor and Klöckner Pentaplast are leading the way in developing innovative, recyclable blister packaging solutions, such as the AmSky system, which eliminates the use of PVC. These advancements are supported by government policies aimed at reducing non-biodegradable plastics and promoting sustainable practices in the pharmaceutical packaging sector. As the industry continues to evolve, the focus on environmentally friendly and efficient packaging solutions is expected to shape the future of the pharmaceutical blister packaging market.

Explore More

Pharmaceutical Blister Packaging Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.2.1 Bargaining Power of Suppliers

      2. 1.2.2 Bargaining Power of Buyers

      3. 1.2.3 Threat of New Entrants

      4. 1.2.4 Threat of Substitutes

      5. 1.2.5 Intensity of Competitive Rivalry

    3. 1.3 Industry Value Chain Analysis

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Material

      1. 2.1.1 Plastic (Poly Vinyl Chloride (PVC), Polypropylene (PP))

      2. 2.1.2 Paper

      3. 2.1.3 Aluminum

    2. 2.2 By Technology

      1. 2.2.1 Cold Forming

      2. 2.2.2 Thermoformed

    3. 2.3 By Geography

      1. 2.3.1 North America

      2. 2.3.2 Europe

      3. 2.3.3 Asia

      4. 2.3.4 Australia and New Zealand

      5. 2.3.5 Middle East and Africa

      6. 2.3.6 Latin America

Pharmaceutical Blister Packaging Market Size FAQs

The Pharmaceutical Blister Packaging Market size is expected to reach USD 22.08 billion in 2024 and grow at a CAGR of 7.45% to reach USD 31.62 billion by 2029.

In 2024, the Pharmaceutical Blister Packaging Market size is expected to reach USD 22.08 billion.

Pharmaceutical Blister Packaging Market Report Snapshots

Pharmaceutical Blister Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)